AEGIS TECHNOLOGY COMPANY LIMITED – Trademark Portfolio
Entity Type: 98
AEGIS TECHNOLOGY COMPANY LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AEGIGLAM and AEGIVITA.
Room 701, Building 7-C, No.15 Rongyuan Road,
Huayuan Industrial Park, Binhai New Area High Tech Zone Tianjin City
Showing of trademarks Trademarks
Trademark Classifications
AEGIS TECHNOLOGY COMPANY LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does AEGIS TECHNOLOGY COMPANY LIMITED have?
AEGIS TECHNOLOGY COMPANY LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does AEGIS TECHNOLOGY COMPANY LIMITED file in?
AEGIS TECHNOLOGY COMPANY LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are AEGIS TECHNOLOGY COMPANY LIMITED's most well-known trademarks?
AEGIS TECHNOLOGY COMPANY LIMITED's registered trademark portfolio includes well-known marks such as AEGIGLAM and AEGIVITA. These are among 2 currently registered trademarks in the portfolio.
What is AEGIS TECHNOLOGY COMPANY LIMITED's trademark registration success rate?
AEGIS TECHNOLOGY COMPANY LIMITED has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.